{"id":6793,"date":"2025-08-04T17:20:39","date_gmt":"2025-08-04T21:20:39","guid":{"rendered":"https:\/\/www.bu.edu\/psych\/?post_type=profile&#038;p=6793"},"modified":"2025-08-04T18:11:22","modified_gmt":"2025-08-04T22:11:22","slug":"yakeel-quiroz","status":"publish","type":"profile","link":"https:\/\/www.bu.edu\/psych\/profile\/yakeel-quiroz\/","title":{"rendered":"Yakeel Quiroz"},"content":{"rendered":"<p><strong>Director:\u00a0 <a href=\"https:\/\/bostonmapp.org\/\">Multicultural Alzheimer\u2019s Prevention &amp; Protection (MAPP) Lab<\/a><\/strong><\/p>\n<p>Dr. Quiroz is Professor in the Department of Psychological &amp; Brain Sciences at Boston University, where she leads the Multicultural Alzheimer\u2019s Prevention &amp; Protection (MAPP) Lab. She previously served as Associate Professor of Psychiatry at Harvard Medical School and spent over a decade at Massachusetts General Hospital (MGH) directing innovative clinical and research initiatives. Dr. Quiroz earned her MA in cognitive neuroscience and PhD in clinical psychology from Boston University and completed specialized postdoctoral training in neuropsychology and neuroimaging at MGH\/Harvard Medical School.<\/p>\n<p>Her research focuses on identifying early cognitive and biological markers of Alzheimer\u2019s disease and uncovering mechanisms that support cognitive resilience and delay dementia onset. For over 20 years, she has studied Colombian families with early-onset autosomal dominant Alzheimer\u2019s disease (ADAD) caused by mutations in the\u00a0Presenilin-1(PSEN1) gene. With near-complete penetrance and symptom onset in the forties, these families offer a rare opportunity to track the biological trajectory of AD from preclinical to clinical stages\u2014and to investigate protective mechanisms in individuals who remain cognitively resilient despite carrying the mutation.<\/p>\n<p>Dr. Quiroz leads multiple NIH-funded studies, including the Colombia-Boston (COLBOS) biomarker study of autosomal-dominant Alzheimer\u2019s disease, the Boston Latino Aging Study (BLAST), and the Healthy Aging and Resilient Brain Study on genetic modifiers of cognitive resilience. She is also a Co-Investigator on the Harvard Aging Brain Study (HABS) and the Alzheimer\u2019s Clinical Trials Consortium (ACTC).<\/p>\n<p>Dr. Quiroz\u2019s work has earned national and international recognition, including the NIH Director\u2019s Pioneer Early Independence Award, the International Neuropsychological Society (INS) Early Career Award, and the Alzheimer\u2019s Association\u2019s Inge Grundke-Iqbal Award for most impactful research.<\/p>\n<p><em>Information on Dr. Quiroz\u2019s research publications can be found at the <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/myncbi\/yakeel.quiroz.1\/bibliography\/public\/\">US National Library of Medicine<\/a>.<\/em><\/p>\n","protected":false},"author":1569,"template":"","_links":{"self":[{"href":"https:\/\/www.bu.edu\/psych\/wp-json\/wp\/v2\/profile\/6793"}],"collection":[{"href":"https:\/\/www.bu.edu\/psych\/wp-json\/wp\/v2\/profile"}],"about":[{"href":"https:\/\/www.bu.edu\/psych\/wp-json\/wp\/v2\/types\/profile"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/psych\/wp-json\/wp\/v2\/users\/1569"}],"version-history":[{"count":1,"href":"https:\/\/www.bu.edu\/psych\/wp-json\/wp\/v2\/profile\/6793\/revisions"}],"predecessor-version":[{"id":6795,"href":"https:\/\/www.bu.edu\/psych\/wp-json\/wp\/v2\/profile\/6793\/revisions\/6795"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/psych\/wp-json\/wp\/v2\/media?parent=6793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}